R M Regez - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Nederlands Tijdschrift Voor Geneeskunde|January 9, 2008

[No HIV test: a chance missed]G E L van den Berk, A A Jarbandhan, R M Regez, et al.

Lancet (London, England)|December 20, 2003

Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppressionM Hoogewerf, R M Regez, W E M Schouten, et al.

Journal of Clinical Microbiology|August 9, 2003

Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2G E L van den Berk, P H J Frissen, R M Regez, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002

[Safety regarding invasive procedures in HIV-positive patients]R M Regez, R G H Speekenbrink, P M Landsaat, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002

[Post-exposure treatment against HIV outside of the hospital in Amsterdam, January-December 2000]G J B Sonder, R M Regez, K Brinkman, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002

[Reducing the risk of blood-transmitted infections of HIV, hepatitis B or C virus in a teaching hospital in Amsterdam--evaluation of a protocol for needlestick accidents among hospital staff during the period 1997-2001]R M Regez, P J G M Rietra, C Th M van der Linden, et al.

Scandinavian Journal of Infectious Diseases|January 1, 1997

Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control studyH M Weigel, E de Vries, R M Regez, et al.

AIDS Research and Human Retroviruses|March 1, 1997

Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected personsS M Bruisten, P H Frissen, P Van Swieten, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Nederlands Tijdschrift Voor Geneeskunde|January 9, 2008

[No HIV test: a chance missed]G E L van den Berk, A A Jarbandhan, R M Regez, et al.

Lancet (London, England)|December 20, 2003

Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppressionM Hoogewerf, R M Regez, W E M Schouten, et al.

Journal of Clinical Microbiology|August 9, 2003

Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2G E L van den Berk, P H J Frissen, R M Regez, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002

[Safety regarding invasive procedures in HIV-positive patients]R M Regez, R G H Speekenbrink, P M Landsaat, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002

[Post-exposure treatment against HIV outside of the hospital in Amsterdam, January-December 2000]G J B Sonder, R M Regez, K Brinkman, et al.

Nederlands Tijdschrift Voor Geneeskunde|April 18, 2002

[Reducing the risk of blood-transmitted infections of HIV, hepatitis B or C virus in a teaching hospital in Amsterdam--evaluation of a protocol for needlestick accidents among hospital staff during the period 1997-2001]R M Regez, P J G M Rietra, C Th M van der Linden, et al.

Scandinavian Journal of Infectious Diseases|January 1, 1997

Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control studyH M Weigel, E de Vries, R M Regez, et al.

AIDS Research and Human Retroviruses|March 1, 1997

Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected personsS M Bruisten, P H Frissen, P Van Swieten, et al.

Pageof 1